KDM1A and esophageal squamous cell carcinoma: Here, we provide functional data showing that LSD1 is required for ESCC growth, based on our in vitro and in vivo experiments using the LSD1-specific inhibitor SP2509 and shRNA-mediated LSD1 knockdown, indicating that LSD1 may serve as a viable target and prognostic biomarker for ESCC.